Reproductive issues and multiple sclerosis: 20 questions

被引:7
作者
Carlson, Alise K. [1 ]
Ontaneda, Daniel [1 ,2 ]
Rensel, Mary R. [1 ,2 ]
Cohen, Jeffrey A. [1 ,2 ]
Kunchok, Amy [1 ,2 ]
机构
[1] Cleveland Clin, Mellen Ctr, U10,9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Neurol, Cleveland, OH USA
关键词
SAFETY; PREGNANCY;
D O I
10.3949/ccjm.90a.22066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple sclerosis (MS) is commonly diagnosed in young adults during their reproductive years. Consequently, concerns about family planning and MS management related to pregnancy and breastfeeding are often encoun-tered in clinical practice. Pregnancy itself is not harmful for women with MS. However, disease-modifying thera-pies (DMTs) have implications for reproductive planning, including stopping treatment while trying to conceive and during pregnancy, as well as managing fetal risks. People with MS and their care team must engage in collabora-tive decision-making before, during, and after pregnancy. Based on the results of a consensus-building initiative, answers are provided to 20 frequently asked questions regarding the management of MS during pregnancy planning, pregnancy, and the postpartum period.
引用
收藏
页码:235 / 243
页数:9
相关论文
共 55 条
[1]  
ACR Committee on Drugs and Contrast Media, 2022, ACR manual on contrast media
[2]   Rituximab versus Fingolimod after Natalizumab in Multiple Sclerosis Patients [J].
Alping, Peter ;
Frisell, Thomas ;
Novakova, Lenka ;
Islam-Jakobsson, Protik ;
Salzer, Jonatan ;
Bjorck, Anna ;
Axelsson, Markus ;
Malmestrom, Clas ;
Fink, Katharina ;
Lycke, Jan ;
Svenningsson, Anders ;
Piehl, Fredrik .
ANNALS OF NEUROLOGY, 2016, 79 (06) :950-958
[3]  
[Anonymous], RIT RIT PACK INS
[4]   Genetics and familial distribution of multiple sclerosis: A review [J].
Balcerac, A. ;
Louapre, C. .
REVUE NEUROLOGIQUE, 2022, 178 (06) :512-520
[5]  
Banner Life Sciences LLC, BAF MON FUM PACK INS
[6]  
Bayer HealthCare Pharmaceuticals Inc, BET INT 1B PACK INS
[7]  
Biogen Inc, TECF DIM FUM PACK IN
[8]  
Biogen Inc, TYSABRI NATALIZUMAB
[9]  
Biogen Inc, VUM DIR FUM PACK INS
[10]  
Biogen Inc, AV INT BET 1A PACK I